The global pharmacy benefit management market size is accounted at USD 670.19 billion in 2025 and is forecasted to hit around USD 1,474.64 billion by 2034, representing a CAGR of 9.17% from 2025 to 2034. The North America market size was estimated at USD 594.77 billion in 2024 and is expanding at a CAGR of 9.20% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmacy Benefit Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmacy Benefit Management Market, by Service
8.1.1 Specialty Pharmacy Services
8.1.1.1. Market Revenue and Forecast
8.1.2. Benefit Plan Design & Administration
8.1.2.1. Market Revenue and Forecast
8.1.3. Formulary Management
8.1.3.1. Market Revenue and Forecast
8.1.4. Pharmacy Claims Processing
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Pharmacy Benefit Management Market, by Service Provider
9.1.1. Retail Pharmacies
9.1.1.1. Market Revenue and Forecast
9.1.2. Insurance Companies
9.1.2.1. Market Revenue and Forecast
9.1.3. Standalone Pharmacy Benefit Management Providers
9.1.3.1. Market Revenue and Forecast
10.1. Pharmacy Benefit Management Market, by Business Model
10.1.1. Government Health Programs
10.1.1.1. Market Revenue and Forecast
10.1.2. Employer-sponsored Programs
10.1.2.1. Market Revenue and Forecast
10.1.3. Health Insurance Management
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service
11.1.2. Market Revenue and Forecast, by Service Provider
11.1.3. Market Revenue and Forecast, by Business Model
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service
11.1.4.2. Market Revenue and Forecast, by Service Provider
11.1.4.3. Market Revenue and Forecast, by Business Model
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service
11.1.5.2. Market Revenue and Forecast, by Service Provider
11.1.5.3. Market Revenue and Forecast, by Business Model
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service
11.2.2. Market Revenue and Forecast, by Service Provider
11.2.3. Market Revenue and Forecast, by Business Model
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service
11.2.4.2. Market Revenue and Forecast, by Service Provider
11.2.4.3. Market Revenue and Forecast, by Business Model
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service
11.2.5.2. Market Revenue and Forecast, by Service Provider
11.2.5.3. Market Revenue and Forecast, by Business Model
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service
11.2.6.2. Market Revenue and Forecast, by Service Provider
11.2.6.3. Market Revenue and Forecast, by Business Model
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service
11.2.7.2. Market Revenue and Forecast, by Service Provider
11.2.7.3. Market Revenue and Forecast, by Business Model
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service
11.3.2. Market Revenue and Forecast, by Service Provider
11.3.3. Market Revenue and Forecast, by Business Model
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service
11.3.4.2. Market Revenue and Forecast, by Service Provider
11.3.4.3. Market Revenue and Forecast, by Business Model
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service
11.3.5.2. Market Revenue and Forecast, by Service Provider
11.3.5.3. Market Revenue and Forecast, by Business Model
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service
11.3.6.2. Market Revenue and Forecast, by Service Provider
11.3.6.3. Market Revenue and Forecast, by Business Model
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service
11.3.7.2. Market Revenue and Forecast, by Service Provider
11.3.7.3. Market Revenue and Forecast, by Business Model
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service
11.4.2. Market Revenue and Forecast, by Service Provider
11.4.3. Market Revenue and Forecast, by Business Model
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service
11.4.4.2. Market Revenue and Forecast, by Service Provider
11.4.4.3. Market Revenue and Forecast, by Business Model
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service
11.4.5.2. Market Revenue and Forecast, by Service Provider
11.4.5.3. Market Revenue and Forecast, by Business Model
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service
11.4.6.2. Market Revenue and Forecast, by Service Provider
11.4.6.3. Market Revenue and Forecast, by Business Model
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service
11.4.7.2. Market Revenue and Forecast, by Service Provider
11.4.7.3. Market Revenue and Forecast, by Business Model
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service
11.5.2. Market Revenue and Forecast, by Service Provider
11.5.3. Market Revenue and Forecast, by Business Model
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service
11.5.4.2. Market Revenue and Forecast, by Service Provider
11.5.4.3. Market Revenue and Forecast, by Business Model
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service
11.5.5.2. Market Revenue and Forecast, by Service Provider
11.5.5.3. Market Revenue and Forecast, by Business Model
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SS&C Technologies, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Anthem Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medimpact
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Express Scripts Holding Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Benecard Services, LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CaptureRx Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Change Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OptumRx, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Cigna
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample